Summary: Haptoglobin (Hp) is a haemoglobin-binding acute phase protein with three genetic types: Hp 1-1, Hp 2-1, Hp 2-2. We investigated 45 patients during the first 48 hours of acute myocardial infarction, and studied determinant factors and clinical correlates. Upon hospital admission, serum haptoglobin concentration was increased (1.95 ± 0.94 g/1, mean ± SD, P < 0.001) versus the reference population (0.97 ± 0.46 g/l, n = 107), independent of haptoglobin type: 1.84 ± 0.64 g/1 (Hp 1-1, n = 11) (P < 0.01), 1.98 ± 0.79 g/l (Hp 2-1, n = 25) (P < 0.001), 1.98 ± 1.58 g/l (Hp 2-2, n = 9) (P < 0.001). Moreover, during the first hours of hospitalization, a temporal lowering of haptoglobin was observed suggesting acute haemolysis, independent of the haptoglobin type. Minimal serum haptoglobin was reached 9.6 ± 5.8 hours after admission. The amplitude of the haptoglobin decrease correlated with initial serum haptoglobin (r = 0.78) and was more pronounced (P < 0.05) in men (0.53 ± 0.57 g/1) than in women (0.18 ± 0.17 g/1). Decrease of serum haptoglobin did not correlate with infarct size (based on creatine kinase-MB release). Out of the other acute phase proteins measured upon admission, only C-reactive protein was significantly increased (P < 0.05). During the next 36 hours, haptoglobin increased as a result of the acute phase response to myocardial injury. Our findings suggest that acute myocardial infarction is also preceded by an acute phase response, characterized by an initial high haptoglobin and followed by a temporal haptoglobin decrease due to haemolysis.
Introduction
Atherogenesis and acute myocardial infarction are known to be associated with inflammation (1) and limited haemolysis. As haptoglobin (Hp) is involved both in acute phase reaction (2) and haemolysis (3) we studied the evolution of haptoglobin concentration during the early phase of acute myocardial infarction.
Three genetically determined haptoglobin phenotypes are known: Hp 1-1, Hp 2-1, and Hp 2-2, each with its type-specific reference values (2, 4) . In the days following acute myocardial infarction, increased haptoglobin concentrations are found, with a maximum about one week after onset of acute myocardial infarction (5) (6) (7) (8) . In addition to its role as an acute phase reactant, haptoglobin possibly fulfils regulatory functions during acute myocardial infarction (7) such as inhibition of platelet aggregation by crude and highly purified a r acid-glycoprotein (9) . Functional differences between haptoglobin types are known (2) . Inhibition of prostaglandin synthesis is type-dependent (2) . Haptoglobin polymorphism has been shown to correlate with severity and outcome of acute myocardial infarction (7) . The aim of this study was to evaluate haptoglobin concentration during the first 36 hours after onset of acute myocardial infarction, and to study determinant factors and clinical correlates of the observed pattern (haptoglobin type, infarct size, acute phase proteins, ...). Inflammation upon admission was evaluated by measuring the following acute phase proteins; a r acid glycoprotein, a r antiproteinase (cii-antitrypsin), a 2 -macroglobulin and C-reactive protein. As haptoglobin is characterized by a variation of the carbohydrate moiety as well (2) , this heterogeneity was also studied.
Materials and Methods

Study protocol
The study inclusion criterion was the presence of significant Pardee waves (ST elevations of at least 2 mm in at least 2 adjacent leads) in the electrocardiogram for at least 30 minutes on admission. Diagnosis of acute myocardial infarction was established according to WHO criteria (10). Serum samples from 45 patients admitted because of acute myocardial infarction (33 men, age: 58.7 ± 12.3 years; 12 women, age: 61.6 ± 12.2 years; mean ± SD) were analyzed. Healthy blood donors (n = 107, age: 41 ±11 years) served as a reference population. Blood was sampled upon hospital admission, then every 4 hours until the 16th hour, and further at the 24th, 30th and 36th hour after admission.
Biochemical determinations
Total creatine kinase 1 ) activity was measured at 37 °C according to IFCC (11) with a RA-1000 analyzer (Technicon, Tarrytown, NY, USA), using CK-NAC reagents (J. T. Baker, Deventer, The Netherlands). Creatine kinase-MB isoenzyme activity was measured using immunoprecipitation (Isoimmune-CK™, Roche, Nutley, NJ, USA) (12) . Infarct size was calculated out of cumulative creatine kinase-MB isoenzyme release (13, 14) . Serum haptoglobin, αϊ-acid glycoprotein, ctrantiproteinase, a 2 -macroglobulin, and C-reactive pro-') Enzymes: Creatine kinase (EC 2.7.3.2) tein concentrations were determined with a BN Nephelometer (Behringwerke, Marburg, Germany) (15) . Results were expressed according to IFCC standards (16) . Haptoglobin typing was carried out according to Smithies (17) . Variation in the carbohydrate moiety of haptoglobin were studied by affinity chromatography toward concanavalin A-Sepharose (18) .
Statistics
Results are expressed as mean ± standard deviation. Haptoglobin type frequencies in the patients and reference group were compared using χ 2 testing with Yates' correction. Comparisons between the amplitude of haptoglobin decrease and infarct size and between the amplitude of haptoglobin decrease and initial haptoglobin concentration were made using a Spearman rank correlation test. Results were compared according to haptoglobin type using non-parametric statistics (Kruskal-Wallis). Statistical significance was considered at the level of Ρ < 0.05.
Results
Acute phase protein concentration in acute myocardial infarction upon admission Upon admission (173 ± 68 min after onset of symptoms, creatine kinase 209 ± 245 U/l), serum haptoglobin concentration in acute myocardial infarction (1.95 ± 0.94 g/1) was increased compared to the reference population (0.97 ± 0.46 g/l; P < 0.001). Table 1 shows haptoglobin concentrations according to haptoglobin type. For the three haptoglobin types, haptoglobin concentration was significantly higher (P < 0.01 for Hp 1-1, P < 0.001 for a For acute myocardial infarction patients, serum haptoglobin concentration given upon hospital admission. * P < 0.01; **P< 0.001 compared to the reference population * P < 0.05, ** P < 0.01 a Derived from individual data from a reference population measured in our laboratory which took part in a multicentre evaluation program (I.e. (15)).
lin and haptoglobin on admission and compares them with our reference population (15) . Only haptoglobin and C-reactive protein were increased compared to the reference population.
Evolution of haptoglobin concentration during acute myocardial infarction
In acute myocardial infarction, haptoglobin concentrations were serially followed during the first 36 hours after admission ( fig. 1 ). Upon admission, haptoglobin concentration was increased. In the following hours, a temporary lowering of haptoglobin concentration is observed. This initial lowering is followed shortly by a gradual increase of haptoglobin concentration, which is compatible with the role of haptoglobin as an acute phase reactant after acute myocardial infarction. Minimal haptoglobin concentrations were found 9.6 ± 5.8 h (range: 2.0-33.0 h) after admission. The observed change from admission in haptoglobin concentration was 0.44 ± 0.52 g/1 (range 0.03-2.69 g/1) and was comparable among haptoglobin types (tab. 3) and not related to infarct size estimated by creatine kinase-MB isoenzyme release (Spearman r = 0.17). Significant differences in haptoglobin concentration decrease were observed according to gender. For male patients (n = 33), the haptoglobin decrease was 0.53 ± 0.57 g/1 vs. 0.18 ±0.17 g/1 for female patients (n = 12) (P < 0.05). The decrease of haptoglobin concentration correlated with haptoglobin concentration upon admission: y (haptoglobin decrease, g/1) = 0.43 (serum haptoglobin upon admission, g/1) -0.40; r = 0.78, S xy = 0.33.
Microheterogeneity of haptoglobin upon admission
Concanavalin A affinity chromatography showed that 65 ± 19% of serum haptoglobin in acute myocardial infarction upon admission bound to the lectin (tab. 2). The concanavalin A binding fraction is lower than in the reference population (86 ± 7%, P < 0.05). No differences in concanavalin A binding according to haptoglobin type were observed.
Discussion
In the reference population and in acute myocardial infarction patients, the distribution of haptoglobin types corresponds to other European studies (2) . Haptoglobin type distribution in both controls and acute myocardial infarction patients was in agreement with the HardyWeinberg equilibrium.
Upon admission, increased haptoglobin concentrations were found in a large majority of acute myocardial infarction patients independently of haptoglobin type. However, haptoglobin concentration in the reference population was significantly lower in Hp 2-2 carriers, which is in accordance to previously published data (2, 4) . The observation of a simultaneous increase of haptoglobin and C-reactive protein is in contrast to normal concentrations for a r acid glycoprotein, a r antiproteinase and a 2 -macroglobulin in acute myocardial infarction upon admission and points to a stimulation of haptoglobin and C-reactive protein synthesis prior to the infarction. Haptoglobin and C-reactive protein are acute phase proteins, whose synthesis is stimulated by interleukin-6 (2). The response of haptoglobin and C-reactive protein synthesis to interleukin-6 stimulation occurs slowly and becomes obvious after 24 h. Our data suggest that acute myocardial infarction is preceded by an acute phase reaction during the day(s) before the coronary thrombosis. This agrees with other studies in which the relationship between infection and inflammatory processes and the risk for acute myocardial infarction was established (1).
The increased serum haptoglobin concentration in acute myocardial infarction upon admission is in agreement with literature (5 -8) . When comparing haptoglobin values in previous reports (6, 7), after conversion to IFCC standards, higher haptoglobin concentrations are found in this study in Hp 2-2 sera, and lower haptoglobin concentrations in Hp 1-1 sera. Relative molecular mass differs between haptoglobin types (Hp 1-1: M T = 80000, Hp 2-1: M T = 120000, Hp 2-2: M T = 160000). This leads to different diffusion rates between the haptoglobin types which results in an underestimation of Hp 2-2 concentration with the radial immunodiffusion technique (2, 4, 19) . This might explain the lower Hp 1-1 and higher Hp 2-2 concentrations determined by nephelometry in this study compared to studies using radial immunodiftusion (6, 7).
After admission, a temporary lowering of haptoglobin concentration is found in acute myocardial infarction, which was not reported in previous studies (5) (6) (7) (8) . The latter is not surprising, as the minimal haptoglobin concentration is observed 9.6 ± 5.8 h after admission and blood samples for haptoglobin determination in the former studies were only collected once daily. In our study the amplitude of the lowering depends on the initial haptoglobin concentration. However, this finding should be viewed with caution. Given a haemolytic pulse as part of the evolution of acute myocardial infarction, the decrease in haptoglobin theoretically might be unrelated to the initial concentration. The initial lowering of haptoglobin concentration following acute myocardial infarction can be explained by haemoglobin-binding. After consumption of haptoglobin, haemopexin levels start to decrease, whereas haptoglobin concentration remains low (< 0.3 g/1) (3). In this study, complete consumption of haptoglobin was observed in 2 acute myocardial infarction cases (5%). Elimination of haemoglobin-haptoglobin complexes by the liver occurs faster because of the rapid recognition by receptors localized at the membrane of liver parenchyma (2) . The lowering of haptoglobin during the first hours after admission suggests a moderate acute haemolysis. Based on a haemoglobinhaptoglobin binding ratio of 1 : 1, the observed decrease in haptoglobin concentration corresponds with a haemolysis of ± 10 ml erythrocytes, equivalent to a complete haemolysis of ± 22 ml of blood. This might be caused by acute changes in red cell survival induced by regional changes of the blood flow (20) . Interestingly, our observation of haptoglobin lowering differs significantly according to gender. Rheological properties of whole blood are sex-related: total shear stress of whole blood being lower in females (21) . From the second day of hospitalization, the slowly increasing haptoglobin concentration takes part of the acute phase reaction.
The observed haemolysis has consequences for the estimation of acute myocardial infarction size based on the release of -hydroxybutyrate dehydrogenase (EC 1.1.1.30) (22) since erythrocytes contain considerable amounts of this enzyme. So, the observed haemolysis may cause an overestimation of acute myocardial infarction size when using methods based on release of ahydroxybutyrate dehydrogenase.
The difference in affinity of haptoglobin towards concanavalin A in acute myocardial infarction on admission suggests an altered glycosylation of haptoglobin prior to acute myocardial infarction. Concanavalin A has an affinity towards mannose and glucose related structures (18) . Increase in sialic acid content reduces the binding towards concanavalin A (23). The concanavalin A non-binding fraction of haptoglobin does not form complexes with haemoglobin (24) , so the haemoglobin-binding capacity of haptoglobin is reduced during the early phase of acute myocardial infarction. Furthermore, recent findings postulate a role for haptoglobin in homing and trafficking of B lymphocytes (25) .
The increased haptoglobin concentration in acute myocardial infarction upon admission, followed by a temporary decrease due to a limited haemolysis and the altered glycosylation of haptoglobin in acute myocardial infarction upon admission suggest an involvement of haptoglobin in the complex mechanism leading to acute myocardial infarction. Further studies will be needed to investigate the specificity of our findings and the interaction between haptoglobin and the complex mechanism leading to acute myocardial infarction.
